Posted by AGORACOM-JC
at 5:25 PM on Thursday, January 6th, 2022
The global e-commerce market surpassed $9 TRILLION in 2019 … and is scheduled to grow by a CAGR of 14% into 2027 … But mega brands control almost 70% of the US market alone and are using their strength to win even more market … making it harder for SMBs to compete in this massive market.
Logiq …. a public company for just 4 months…. is an award-winning e-commerce and fintech solutions company that is addressing that problem by helping drive e-commerce for SMBs around the world … with revenues of $37.9M in 2020 …. from 2 divisions:
AppLogiq (Agreement finalized to Transfer AppLogiq Assets into Publicly Traded Subsidiary) – In Southeast Asia AL offers a mobile application development platform as-a-service which enables hundreds of thousands of SMBs to create mobile apps with little technical expertise or know-how … Offered across Southeast Asia, Europe and U.S. in 14 languages .. …. also offers a mobile fintech payment platform (PayLogiQ) and a hyper-local food delivery service (GoLogiq)
DataLogiq – provides a data-driven, end-to-end e-commerce marketing solution that integrates AI to help SMBs in need of online marketing solutions.
Financial Highlights:
2020 revenue of $37.9 million … 31% CAGR since 2016
Revenue H1-21 $16.4 million
Revenue Q2-21 $8.3 million …
margin of 29.5%
up 16.4 percentage points from the year-ago quarter.
Revenue Q3-21 $7.8 million
margin for DataLogiq: improved from 18.9% to 28.2%.
margin for AppLogiq: improved from 12.1% to 31.7%.
Q4-21 Revenue Estimate: $12.3 million, up 87% vs Q4-20
Gross margin expected to 34.0% vs 29.5% in the previous Q / 21.1% in Q4-20
Brent Suen, president of Logiq commented,
“Our improving revenue performance throughout 2021 demonstrates our team’s commitment to driving a transformation of our business overall and providing visibility on future profitability. As we refocused our efforts on higher quality, more profitable revenue streams and adjusted to the changing market dynamics, we also drove strong gross margin improvement every quarter of 2021. In fact, our gross margin more than doubled in Q4 2021 compared to the full year of 2020.”
Suen continued,
“We believe this strong progress across the board is keeping us on the path to profitability for both of our business segments,” continued Suen. “It also advances our plans to separate our DataLogiq and AppLogiq businesses into two independent publicly traded companies as another way to further unlock shareholder value.”
Now sit back, relax and watch this powerful interview.
In this episode of the Psychedelic Therapy Frontiers podcast, Dr. Steve Thayer and Dr. Reid Robison are joined by Jeremiah Robison to talk about work-life balance. Jeremiah is the Founder and CEO of Shroom Beach, a psychedelic-inspired clothing company that donates 10% of its profits to fund psychedelic medicine research
Both articles highlight how the new clinic will focus on treating substance use disorders and addiction-related illnesses led by incoming medical director Amy de la Garza.
Blossom summarizes the exciting progress made on treating eating disorders with psychedelics. It’s a passion which our Chief Medical Officer, Dr. Reid Robison shares, working for years to bring innovative and effective treatment options to people suffering. Recently, Dr. Robison presented a keynote on the topic at the MindMed Australia International Summit on Psychedelic Therapies for Mental Illness. You can watch it here.
Three more Canadians received legal access in a big win that “opens it up to everyone,” but there are still issues with the system overall. “The process is still broken.” The Vancouver Sun explores how even with such positive news, there is still a lot of ground to cover in Therapsil’s fight for expanded access to psychedelic medicine.
No. We are not out of the woods. The Omicron variant is spreading quickly and with it, a slew of public health restrictions and fears reminiscent of March 2020. What can’t get lost in the shuffle again is addressing mental health. Especially for those on the frontlines of healthcare. “This sense of endlessness, accompanied by growing psychological distress leading to depression, was a recurrent theme in two dozen interviews conducted in Asia, Europe, Africa and the Americas. After two years of zigzagging policy and roller coaster emotions, terrible loss and tantalizing false dawns, closing borders and intermittently shuttered schools, people’s resilience has dwindled.” Frontline ketamine-assisted psychotherapy registration is still open for the next group of participants. Learn more here.
Salt Lake City Clinic welcomes incoming addictions specialist, Dr. Amy de la Garza
We are pleased to announce the opening of a new clinic located in downtown Salt Lake City (SLC). In addition to Novamind’s suite of mental health treatments, the SLC Clinic specializes in integrative behavioural health and services for adults with substance use disorders (SUD) led by incoming Medical Director, Dr. Amy de la Garza.
The SLC Clinic’s outpatient SUD services provide an alternative to residential treatment programs and work to address the highly complex public health crisis that is worsening alongside challenges related to access. In 2020 alone, 93,000 Americans died of a drug overdose-an increase of 30 per cent from the previous year, according to the Centers for Disease Control and Prevention.
Dr. Reid Robison, Novamind’s Chief Medical Officer, commented: “Social isolation and despair related to the COVID-19 pandemic have further fueled a significant increase in substance use disorders and related deaths. Dr. de la Garza’s expertise in addiction medicine and behavioural health is a vital addition to our team as we continue to expand Novamind’s clinic footprint to address unmet need and broaden our innovative, evidence-based treatments.”
Dr. de la Garza is a board-certified family practice physician with 10 years of experience providing specialized care for patients with behavioral health and SUD diagnoses. She earned her Doctorate in Medicine from the University of Colorado before completing a Family Medicine Residency at the Utah Healthcare Institute. She also completed an Addiction Medicine Fellowship at the University of Utah and is an Institute for Functional Medicine Certified Practitioner. In 2017, Dr. de la Garza opened the first community-based, co-located primary care and behavioral health practice in Salt Lake City, Utah.
“I am thrilled to join Novamind and look forward to establishing an innovative outpatient substance use disorder program that brings together addiction and integrative medicine and treats the whole person,” said Dr. de la Garza, who is also trained in integrative modalities and lifestyle medicine, including nutrition, movement, sleep, stress management and social connection.
Novamind will collect clinical data on the efficacy of the integrative treatment approach for SUD and host upcoming studies for conditions like opioid use disorder. Additionally, the SLC Clinic will pilot an innovative and cost-effective group medical visit model that has been shown to reduce anxiety and depression, as well as improve outcomes in chronic conditions like cardiovascular disease and diabetes.
The SLC Clinic is located at 807 E South Temple, Suite 101, Salt Lake City, Utah.
In this episode of the Psychedelic Therapy Frontiers podcast, Dr. Steve Thayer and Dr. Reid Robison explore anxiety. They discuss the following topics and much more: • What is an anxiety disorder? • Anxiety management skills • The role of medicines in treating anxiety
Utah Business covers Dr. Reid Robison and the success of ketamine-assisted psychotherapy in our clinics. “While it’s still early and much more testing is to be done, Robison describes what’s happening in mental health care as a ‘psychedelic renaissance’.”
Dr. Reid Robison, Matt Johnson and Robin Carhart-Harris discuss The Science of Psychedelics: Therapeutic mechanisms and clinical outcomes for a range of mental illnesses and other conditions.
Chief Medical Officer Dr. Reid Robison’s keynote presentation at the Mind Medicine Australia International Summit on Psychedelic Therapies for Mental Illness.
“While the U.S. has been battling Covid-19 it’s gotten lost in the shuffle that the nation had record numbers of drug overdose-related deaths in 2020; approximately 93,000. In addition, from May 2020 through April 2021, the figure rises to 100,000.” We need better treatment options for people with substance use disorders (SUD). It’s the driving force behind why incoming Novamind Medical Director Dr. Amy de la Garza will lead SUD programming at our new Salt Lake City clinic.
We are currently in a mental health crisis. Depression, anxiety and symptoms of PTSD have run rampant over the last two years, accelerated by the COVID-19 pandemic and its far-reaching effects. The need for new and effective mental health treatments has never been clearer. We have seen the efficacy of ketamine-assisted psychotherapy firsthand. And we are eager to continue psychedelic research. If you’d like to stay up to date on upcoming studies hosted by Novamind, visit us here and get in touch. “So what else does the future hold for psychedelics? For one thing, taking psychedelics could one day be the same as taking an everyday pill prescribed by your doctor.”
Multistate expansion underway, signed LOI to acquire Arizona-based mental health practice
Total revenue of $1,857,750, +113% when compared to same period last year
Total working capital of $6,834,011 to fund operations
“Q1 was a strong start to fiscal year 2022, driven by the addition of another clinic to our network and increased patient demand for our comprehensive range of innovative mental health treatments,” said Yaron Conforti, Novamind’s CEO and Director. “We continue to make progress on our national clinic expansion, most recently with a letter of intent to acquire two locations in Arizona. Our clinical research business has been actively building an exciting pipeline of contracts with leading drug developers.”
“Novamind operates best-in-class psychiatry clinics and clinical research sites, with a proven ability to replicate our clinic model in the U.S. Our agreement with Bienstar is an exciting opportunity to export our clinical expertise and capabilities into international markets,” said Yaron Conforti, Novamind CEO and Director. “Partnering with local operators allows us to disseminate Novamind’s best practices and SOPs globally, with minimal investment and managed risk, ultimately expanding access to psychedelic medicine and innovative mental healthcare on a global scale.”
Novamind’s CEO and Director, Yaron Conforti, will join the Psychedelics Assisted Psychotherapy panel discussion from 1:30 PM to 2:15 PM EST. Mr. Conforti will also deliver a corporate presentation to update investors on recent milestones and progress towards the global expansion of Novamind’s psychedelic clinics and research sites.
In this episode of the Psychedelic Therapy Frontiers podcast, Dr. Steve Thayer and Dr. Reid Robison explore the concept of the “middle way” and the need for balance in an increasingly polarized world.
In a piece for The Guardian, psychedelic pioneer Rick Doblin explains how psychedelics can change humanity for the better. “We envision a day when psychedelics will be more than a last-ditch treatment: they will be a catalyst for mass mental health.”
The work to destigmatize psychedelics has been long and arduous. Just ask Rick Doblin. He’s devoted his life to it. But as more and more research comes out, more and more people are changing their opinion on the once villainized substances. “Public attitudes around psychedelics are shifting: A recent Nanos Research survey, commissioned by the Canadian Psychedelic Association, found that 82 per cent of Canadians are in favour of psilocybin-assisted therapy in end-of-life illness, while 78 per cent of those polled support legalizing it to improve the quality of life for palliative and end-of-life patients.”
Posted by AGORACOM-JC
at 4:03 PM on Wednesday, September 29th, 2021
CurrencyWorks (CWRK: CSE) (CWRK: OTCQB) builds digital currencies for brands, companies, and communities to empower the free exchange of value between customers and users.
On September 24, 2021, bidding began for the Platinum and Elite NFTs. The one-of-one ZERO CONTACT Platinum Edition NFT sold for $56,860.00 USD and the ZERO CONTACT Elite Edition NFTs sold for a total of $36,575.00 USD. Additionally, CurrencyWorks receives an ongoing royalty every time these NFTs are bought and sold.
What did Cameron Chell, Chairman of CurrencyWorks have to say?
“We are extremely proud of the ZERO CONTACT NFTs that CurrencyWorks created on VUELE. This is a significant advancement for film distribution and digital collectibles,” said Cameron Chell, co-head of VUELE and Executive Chairman of CurrencyWorks.
Sit back and watch this powerful interview with company chairman Cameron Chell.
Posted by AGORACOM-JC
at 4:19 PM on Monday, August 9th, 2021
Most of us know drones for their recreational uses or perhaps even as simple commercial applications for things like real estate videos.
But the fact of the matter is that drone usage is about to go parabolic with huge corporations adopting them for a wide-use of applications that most never dreamed of such as:
To provide Internet connections in remote locations.
To collect crowd data.
In short, the drone industry is booming in ways people can’t imagine because the industry is shifting from the drones themselves (hardware) to drone technology and solutions (software)… and the one company that is delivering the most challenging applications is Draganfly Inc. (DPRO: NASDAQ) (DPRO: CSE)
DraganFly is an award-winning drone manufacturer and technology developer that is actually delivering some pretty incredible achievements, milestones and even history:
Established in 1998 DFLY is considered the oldest commercial drone company in the world
Built the first drone that saved a life
Boasts the first drone to be inducted into the Smithsonian National Air & Space Museum
Developing a Vaccine Drone Delivery Payload System (it’s way more complicated than just transporting vaccines)
Detect infectious conditions in a person from a distance of 190 feet
Conduct phenotyping, data collection and analysis by the USDA
With all of this under the Company’s belt, it’s easy to see why the company recently uplisted to the NASDAQ.
If you believe in the massive parabolic growth in the use of drones for almost everything we do in this world, or want to learn, then watch / listen to this powerful interview with Draganfly CEO and Chairman, Cameron Chell.
Posted by AGORACOM-JC
at 5:28 PM on Thursday, August 5th, 2021
HPQ Silicon Resources $HPQ $HPQFF is a Quebec-based company that is developing high value-added silicon products that are sought after by battery and electric vehicle manufacturers – but nobody has yet delivered – until now.
If that sounds a lot like what other small companies are saying lately, $HPQ differentiates itself as a leader of the pack thanks to the following:
To understand the importance and the implications of this milestone, this excerpt from the press release says it all:
” The HPQ NANO team is now more confident than ever that the PUREVAPTM NSiR will be able to deliver, at scale, and on-demand, a nano silicon for anode production that will be cost competitive. The validation announced today …. was the big breakthrough we were looking for”
Peter Pascali, President and CEO of technology partner PyroGenesis added a little more excitement when he stated:
“Words cannot adequately describe the excitement at PyroGenesis at potentially being able to address and solve challenges in developing lithium-ion batteries, which are sought after by many industries but specifically the EV market.”
Using an analogy to describe the importance of this milestone, $HPQ CEO Bernard Tourillon stated it was equivalent to the first SpaceX successful landing of its Falcon rocket. Specifically, though he was confident in their ability to produce Nano Silicon, actually producing it now removes all doubt and the Company can now focus on:
“… Subsequent batches will be delivered to the awaiting automobile manufacturers plus numerous other entities that have demonstrated an interest in receiving samples.“
Watch this great interview with $HPQ CEO Bernard Tourillon to get the full picture on next steps!
Posted by AGORACOM-JC
at 4:06 PM on Monday, July 12th, 2021
As the name implies “PropTech” is a combination of two words and stands for “property technology.” As simple as that is, the implementation and importance of PropTech is anything but, which is why many companies are trying to capitalize on the rapidly growing paradigm shift, while Universal PropTech (UPI:TSXV) is actually delivering healthy building solutions developers, owners and operators across Canada.
This is comprised of awarded and not executed work, made up of a combination of service contracts and project work in both HVAC Building Automation and Mechanical lines of business.
We sat down with Frank Carnevale, CGO of Universal Proptech, to talk about their multimillion-dollar backlog. Check out the full interview below.
Posted by AGORACOM-JC
at 4:53 PM on Tuesday, July 6th, 2021
HPQ Silicon Resources $HPQ $HPQFF is a Quebec-based company that is developing a portfolio of high value-added silicon products sought after by battery and electric vehicle manufacturers.
If that sounds a lot like what other small companies are saying lately, $HPQ differentiates itself as a leader of the pack thanks to the following:
To understand the importance and the implications of this milestone, this excerpt from the press release says it all:
” Demand for higher purity Silicon, materials that the PUREVAP QRR was designed to produce – but one that traditional silicon producers have a difficult time making, is about to enter a massive growth phase, driven by worldwide demand from the silicones, solar, and batteries industries. The Covid-19 pandemic accelerated the closing of old inefficient traditional Silicon plants and combining this with the chronic under investment in new conventional Silicon plants that occurred in the past decade, and the need for more efficient and environmentally friendly processes has created a perfect storm for the industry. HPQ should be a key beneficiary of this new reality.”
Today, thanks to HPQ’s great progress on its silicon mission, the Company announced “An Agreement to Develop a New Environmentally Friendly Process to Manufacture Fumed Silica” What is Fumed Silica? Suffice it to say, it is in heavy demand right now but current producers are going to run into strong environmental “ESG” headwinds as the industry is now moving towards clean and verified Fumed Silica that HPQ Silicon believes it will be able to deliver thanks to its powerful relationship with ESG driven PyroGenesis Canada. The market for Fumed Silica is set to hit $USD 2.2 Billion in 2022 and CEO Tourillon wasn’t shy about his confidence in the Company’s potential to win market share with this quote:
““The business opportunity that this represent should not be underestimated and could be as significant as the ones represented by the PUREVAP™ family of processes we are developing with PyroGenesis”
Watch this great interview with $HPQ CEO Bernard Tourillon – especially the last 13 minutes – to get the full picture!
Posted by AGORACOM-JC
at 6:17 PM on Monday, July 5th, 2021
With $US 3.2M in 2020 revenue, representing a 58% increase over the previous year, you would think Empower Clinics CEO Steve McAuley would use his first interview after the filing to celebrate.
He isn’t.
Rather, with Fiscal 2020 having come to end more than 6 months ago, the 2020 results are a distant rear view mirror shot of a Company that is in full-blown growth mode and can be best summarized as follows:
“Multiple opportunities have been percolating and I’m going to turn up the heat”
To this end McAuley sees a “substantially higher market cap” for the Company, as well as, growth that will be “deserving of an uplist”.
We could try to list all the powerful things he had to say in this interview – but best we let you watch/hear it straight from Steve in this amazing interview.
